KriSan Biotech is a Taiwan-based CDMO founded in 2015, located in Tainan Science Park. They provide one-stop CDMO services for small molecule APIs, peptides, oligonucleotides, antibody-drug conjugates (ADC), and high-potency drugs from preclinical to commercialization. The company has a professional team averaging 10+ years of API experience. KriSan has partnered with CMIC BIO for ADC/XDC innovation, signed MoU with Mycenax for ADC capabilities, and has supplied kg-scale API to companies such as Atossa Genetics (NASDAQ: ATOS) and OncoArendi Therapeutics. They hold PIC/S GMP certification from TFDA.
Small molecule API synthesis, peptide synthesis, oligonucleotide manufacturing, ADC development and manufacturing, high potency drug handling, linker-payload development
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.